Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04328844
Title A Study to Assess a PI3Kdelta Inhibitor (IOA-244) in Patients With Metastatic Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors iOnctura
Indications

malignant mesothelioma

uveal melanoma

ocular melanoma

melanoma

non-Hodgkin lymphoma

Therapies

IOA-244

Age Groups: senior | adult
Covered Countries


No variant requirements are available.